Story

Dr. Martens Reaffirms FY2027 Outlook on Strong US Wholesale Demand

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Dr. Martens Reaffirms FY2027 Outlook on Strong US Wholesale Demand

Summary

The British bootmaker maintained its fiscal 2027 financial targets, citing encouraging wholesale demand in the United States and stable trading since the start of its financial year.

Text size
Background

Dr. Martens on Wednesday reaffirmed its fiscal 2027 outlook, signaling confidence driven by encouraging wholesale demand in the United States, its largest single market. The British footwear brand stated that overall trading has been in line with its expectations since its financial year began in April.

Financial Targets and Performance

The company maintained its guidance, which is based on a company-compiled consensus forecast for an adjusted pretax profit of £68 million (approximately $91.21 million) for fiscal year 2027. This reaffirmation suggests a degree of stability after a period of operational challenges.

In its trading update, Dr. Martens highlighted positive performance in several key regions. The company reported that its business in Japan and South Korea was performing well, while European markets were also meeting expectations despite a challenging consumer backdrop.

Sample IUX Markets – In-articleAd

Market Reaction

Investors initially reacted positively to the news. According to Reuters, shares in Dr. Martens (LSE: DOCS) rose as much as 3.8% to 75.5 pence in early trading on the London Stock Exchange.

However, the early gains were not sustained. The stock later pared its advance, trading flat by 0731 GMT as the market digested the update.

Read next

More on Stocks
Back to latest news

LATEST